GSK Pharmaceuticals Schedules Digital Analyst and Institutional Investor Meet
GlaxoSmithKline Pharmaceuticals Ltd 路 Intimation 路 28 Oct 2026, 9:58 pm
GSK Pharmaceuticals Schedules Digital Analyst and Institutional Investor Meet GlaxoSmithKline Pharmaceuticals Limited has scheduled a group analyst and institutional investor meeting on 4th Nov'26 via a digital platform, in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015. The company stated that only publicly available information will be shared during the interaction, with meeting dates subject to change based on exigencies.
Original exchange filing (PDF)
More announcements from GlaxoSmithKline Pharmaceuticals Ltd
- As per attachment 路 08 Nov 2026
- As per attachment 路 05 Nov 2026
- As per attachment 路 05 Nov 2026
- Analyst meet Presentation 路 04 Nov 2026
- As per attachment 路 04 Nov 2026
- As per attachment 路 04 Nov 2026
- As per attachment 路 04 Nov 2026
- outcome of Meeting 路 04 Nov 2026
